Most cases of never-smokers’ lung cancer treatable with mutation-targeting drugs (IMAGE)
Caption
Pictured above is a radiographic image of a lung tumor in a patient who never smoked but still developed lung cancer. A new study from Washington University School of Medicine in St. Louis estimates that 78% to 92% of lung cancers in patients who have never smoked can be treated with precision drugs already approved by the Food and Drug Administration to target specific mutations in a patient’s tumor.
Credit
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Usage Restrictions
None
License
Original content